HEALWELL AI Announces Voting Results of 2026 AGSM

HEALWELL AI (OTCQX:HWAIF, TSX:AIDX) reported voting results from its June 25, 2026 annual general and special meeting.

Rhea-AI Summary

HEALWELL AI (OTCQX:HWAIF, TSX:AIDX) reported voting results from its June 25, 2026 annual general and special meeting. Shareholders holding about 66.83% of eligible votes were represented. All resolutions passed, including fixing the board at seven, re-electing all directors, reappointing Deloitte, and re-approving the 10% rolling equity incentive plan.

Argus Jun 26 session

-0.88% close to close Open Argus

Details

News Market Reaction – HWAIF

On Jun 26, the day this news came out, HWAIF closed 0.88% below the previous close.

Data tracked by StockTitan Argus for the Jun 26 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF)  ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company held on June 25, 2026 (the "Meeting"). Shareholders representing approximately 66.83% of the votes attributable to HEALWELL's outstanding shares attended the Meeting in person or were represented by proxy.

All matters of business set out in the Company's management information circular dated May 20, 2026 (the "Circular") were passed at the Meeting, including: fixing the number of directors at seven; re-electing the seven incumbent directors; re-appointing Deloitte LLP as auditor of the Company; and re-approving the Company's equity incentive plan, including the 10% rolling limit on the number of Class A Subordinate Voting Shares that may be issued under the plan and all unallocated options, rights and entitlements under the plan.

Additional detail on the voting is set out below.

Election of Directors

387,110,853 votes, or approximately 99.90% of the votes cast at the Meeting, were cast in favour of the fixing the number of directors of the Company at seven.

The details of the proxy voting for the election of the seven director nominees are set out below:

Nominee	Votes For	% For	Votes Withheld	% Withheld
Alexander Dobranowski	382,486,194	99.88%	442,699	0.12%
Tina Raja	382,654,288	99.93%	274,605	0.07%
Sam Englebardt	382,782,549	99.96%	146,344	0.04%
Hamed Shahbazi	382,380,081	99.86%	548,812	0.14%
Erik Danudjaja	382,328,496	99.84%	600,397	0.16%
Ian Kidson	382,759,329	99.96%	169,564	0.04%
Brad Porter	382,416,772	99.87%	512,121	0.13%

 

Re-appointment of Auditors

387,188,429 votes, or approximately 99.92% of the votes cast at the Meeting, were cast in favour of re-appointing Deloitte LLP as the external auditor of the Company and authorizing the Company's board of directors to fix their remuneration.

Re-approval of Equity Incentive Plan

382,167,598 votes, or approximately 99.80% of the votes cast at the Meeting, were cast in favour of re-approving the Company's equity incentive plan dated December 22, 2020, including the rolling 10% limit on the number of Class A Subordinate Voting Shares that may be issued under the plan and all unallocated rights, options and entitlements under the plan.

For more information on the resolutions and the business of the Meeting, readers should refer to the Circular, a copy of which is available under the Company's profile on SEDAR+ at www.sedarplus.com.

James Lee

Chief Executive Officer
HEALWELL AI Inc.

About HEALWELL AI

HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.

For more information:

Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
ir@healwell.ai

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/302983

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were the key voting results from HEALWELL AI's 2026 AGSM for HWAIF shareholders?

HEALWELL AI shareholders approved all resolutions at the 2026 AGSM, including directors, auditor, and equity plan. According to HEALWELL, support exceeded 99% on major items, signaling strong backing for board composition, Deloitte as auditor, and the 10% rolling equity incentive plan.

What shareholder participation level was reported at HEALWELL AI's June 25, 2026 AGSM (HWAIF)?

Approximately 66.83% of votes attached to HEALWELL AI shares were represented at the June 25, 2026 AGSM. According to HEALWELL, this participation included shareholders attending in person or represented by proxy, providing a substantial quorum for voting on all meeting resolutions.

Were all HEALWELL AI director nominees re-elected at the 2026 AGSM for HWAIF?

Yes, all seven incumbent directors of HEALWELL AI were re-elected at the 2026 AGSM. According to HEALWELL, each nominee received at least 99.84% of votes cast, and shareholders also approved fixing the board size at seven directors with about 99.90% support.

Did HEALWELL AI shareholders re-approve the equity incentive plan at the 2026 AGSM (HWAIF)?

Shareholders re-approved HEALWELL AI's equity incentive plan at the 2026 AGSM. According to HEALWELL, about 99.80% of votes cast supported the plan, including a rolling 10% limit on Class A Subordinate Voting Shares and all unallocated options, rights, and entitlements under the plan.

Who was appointed auditor of HEALWELL AI following the June 25, 2026 AGSM (HWAIF)?

Deloitte LLP was re-appointed as HEALWELL AI's external auditor after the June 25, 2026 AGSM. According to HEALWELL, approximately 99.92% of votes cast supported Deloitte's re-appointment and authorized the board of directors to fix the auditor's remuneration for the upcoming term.